Lopez, Cherry .
HRN: 02-04-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2023
CO-AMOXICLAV 625MG (TAB)
03/17/2023
03/24/2023
PO
625mg
BID
Prophylaxis For 2nd Degree Perineal Laceration
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes